![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4152 | |
A61P 25/00 |
(11) | Number of the document | 1793821 |
(13) | Kind of document | T |
(96) | European patent application number | 05772671.3 |
Date of filing the European patent application | 2005-08-10 | |
(97) | Date of publication of the European application | 2007-06-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2005/014969 |
Date | 2005-08-10 |
(87) | Number | WO 2006/016707 |
Date | 2006-02-16 |
(30) | Number | Date | Country code |
2004233635 | 2004-08-10 | JP |
(72) |
YUKI, Satoshi, c/o MITSUBISHI PHARMA CORPORATION, JP
NAKANO, Takuma, c/o MITSUBISHI PHARMA CORPORATION, JP
SUZUKI, Hiroko, c/o MITSUBISHI PHARMA CORPORATION, JP
|
(73) |
Mitsubishi Tanabe Pharma Corporation,
2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505,
JP
|
(54) | PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS |
PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS |